To stimulate innovation and entrepreneurship in both education and research IXA has, in collaboration with the City of Amsterdam, developed the valorisation program IXAnext; Talent for Innovation.
All Amsterdam universities and knowledge institutes are involved: HvA, UvA, VU, Amsterdam UMC and the NWO institutes AMOLF and NIKHEF. In a five year period, 2017-2021, they collaborate in utilizing and disseminate knowledge and stimulate economic activity and entrepreneurship. The program offers facilities and funding, infrastructure, a network, educational measures and much more.
Students with plans for a start-up can profit from the knowledge of mentors found through the platform Startup and Running.
Companies and non-profits can benefit from the latest scientific expertise and research facilities with the Physics on Demand service. The Research Facilities database helps R&D departments to find specialized, high end equipment and instruments.
On Friday November 20 State Secretary Mona Keijzer launched the national SME workshops digitization. The State Secretary for Economic Affairs and Climate talked to SME entrepreneurs and students. During the online event, Mona Keijzer launched the SME workshops by offering them to MKB Nederland. The majority of SME entrepreneurs are aware of the opportunities and […]News
The ten winners of the prestigious Academic Startup Competition 2020 can use the title ‘Best Academic Startup of 2020’ for the coming year. The winning startups were chosen by an expert jury after a thrilling final in which all 20 finalists were asked to pitch. The ten winners were chosen on the basis of their value proposition, the […]News
LUMICKS, a spin-off of Vrije Universiteit Amsterdam, is pleased to announce a collaboration agreement with clinical-stage biotech company Leucid Bio, which seeks to utilize LUMICKS’ z-Movi® Cell Avidity Analyzer (z-Movi) to accelerate entry of immunotherapeutic candidates into clinical trials. The goal of the partnership is to evaluate the efficacy of Leucid Bio’s next-generation chimeric antigen […]News